Indicated for: iron overload
Route of administration: injectable / infusion
Substance: deferoxamine (chelating agent)
ATC: V03AC01 (Various | All other therapeutic products | Iron chelating agents)
Deferoxamine is a medication used for the treatment of iron overload, a condition that can occur after repeated blood transfusions, such as in thalassemia or other hematological disorders. It acts as a chelating agent, binding to excess iron and facilitating its elimination through urine or feces.
The medication is administered as subcutaneous or intravenous injections, usually over the long term. It is effective in preventing complications associated with iron overload, such as organ damage.
Side effects may include injection site reactions, nausea, vomiting, diarrhea, and, in rare cases, hearing or vision loss. Regular monitoring of iron levels and organ function is essential.
Consult your doctor to discuss the benefits and risks of treatment with Deferoxamine. Follow all medical recommendations to ensure treatment effectiveness.